搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
Medscape
1 天
Durable Responses With Barzolvolimab in Chronic Spontaneous Urticaria Study
Patients with chronic spontaneous urticaria improved early, with benefits lasting through the 52-week follow-up for those who ...
6 天
CLDX Stock Down Despite Upbeat Long-Term Data From Urticaria Study
Celldex stock falls due to safety concerns related to the treatment of urticaria patients with barzolvolimab in a phase II study, despite robust efficacy data.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Court filing made public
Helene's wake
Walz, Vance VP debate
California gang busted
Golf Hall of Famer dies
US diagnostic errors study
5 Chinese nationals charged
Ex-detective denied parole
Strike leads to panic-buying
OH gov. declares emergency
Voyager 2 tool turned off
Can't sue Uber over crash
‘Ryan's Hope' actor dies
Dream fire coach Wright
Murdaugh's appeal rejected
CA deepfakes law blocked
Election betting allowed
Valuation reaches $157B
May face additional charges
Factory probed after Helene
AG appeals abortion ruling
ABC News layoffs
Sued over inmate call rules
AZ voter registration glitch
MA new gun law takes effect
Maui wildfire cause report
反馈